MedPath

The effect of oligopin on PCOS

Phase 3
Recruiting
Conditions
polycystic ovarian syndrome.
Polycystic ovarian syndrome
Registration Number
IRCT20140406017139N3
Lead Sponsor
Alborz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
80
Inclusion Criteria

PCOS diagnosis according to Androgen Excess Society criteria: hyperandrogenism (hirsutism) / hyperandrogenemia (testosterone >70ng/dl) and/or oligomenorrhea (<8 spontaneous menses per year) and/or polycystic ovarian morphology on ultrasound
Women aged from 18 to 40 years old
Normal prolactin
normal thyroid function
17-OH progesterone
No evidence of Androgenic hormone secretory tumors
No Cushing's syndrome or acromegaly

Exclusion Criteria

Using either oral contraceptives or steroids hormones during 1 month before the onset of the trial
Using medications that could modify the metabolism during 1 month before the onset of the trial

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath